Abstract :
The study aims to evaluate and compare the efficacy and safety of bivalirudin as against heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction. The results indicate that the use of bivalirudin resulted in a decrease in adverse clinical events and outcomes.